FINWIRES · TerminalLIVE
FINWIRES

RBC Initiates Solid Biosciences at Outperform, Speculative Risk With $18 Price Target

By

Solid Biosciences (SLDB) has an average rating of buy and mean price target of $18.62, according to analysts polled by FactSet.

What else is happening in Research?